Theravance Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.

About TBPH

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. 

CEO
Rick E. Winningham
CEORick E. Winningham
Employees
97
Employees97
Headquarters
South San, California
HeadquartersSouth San, California
Founded
2013
Founded2013
Employees
97
Employees97

TBPH Key Statistics

Market cap
1.07B
Market cap1.07B
Price-Earnings ratio
35.54
Price-Earnings ratio35.54
Dividend yield
Dividend yield
Average volume
352.64K
Average volume352.64K
High today
$20.24
High today$20.24
Low today
$19.88
Low today$19.88
Open price
$20.01
Open price$20.01
Volume
473.00K
Volume473.00K
52 Week high
$21.03
52 Week high$21.03
52 Week low
$7.90
52 Week low$7.90

Stock Snapshot

As of today, Theravance Biopharma(TBPH) shares are valued at $20.09. The company's market cap stands at 1.07B, with a P/E ratio of 35.54.

As of 2026-02-05, Theravance Biopharma(TBPH) stock has fluctuated between $19.88 and $20.24. The current price stands at $20.09, placing the stock +1.1% above today's low and -0.7% off the high.

The Theravance Biopharma(TBPH)'s current trading volume is 473K, compared to an average daily volume of 352.64K.

In the last year, Theravance Biopharma(TBPH) shares hit a 52-week high of $21.03 and a 52-week low of $7.90.

In the last year, Theravance Biopharma(TBPH) shares hit a 52-week high of $21.03 and a 52-week low of $7.90.

TBPH News

Simply Wall St 7d
While shareholders of Theravance Biopharma are in the black over 1 year, those who bought a week ago aren't so fortunate

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking market-beating companies to own shares in. To w...

While shareholders of Theravance Biopharma are in the black over 1 year, those who bought a week ago aren't so fortunate

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.